Benitec Biopharma Q1 EPS $(0.26) Beats $(0.29) Estimate

Benzinga · 19h ago
Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.29) by 10.34 percent. This is a 18.18 percent decrease over losses of $(0.22) per share from the same period last year.